Molecular aspects of thyroid hormone actions

Endocrine Reviews

Volumn 31, Issue 2, 2010, Pages 139-170

  Cheng, Sheue Yann ^a   Leonard, Jack L ^b   Davis, Paul J ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA CATENIN; CELL NUCLEUS RECEPTOR; CELL PROTEIN; CYCLIN D1; DEOXYGLUCOSE; DIIODOTHYRONINE; EARLY GROWTH RESPONSE FACTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; GELSOLIN; IODOTHYRONINE; LEVOTHYROXINE; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; SECURIN; SODIUM PROTON EXCHANGE PROTEIN; TETRAIODOTHYROACETIC ACID; THYROID HORMONE; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR ALPHA1; THYROID HORMONE RECEPTOR BETA; THYROXINE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; THYROID HORMONE RECEPTOR;

ACTIN POLYMERIZATION; ANGIOGENESIS; ASTROCYTE; BRAIN DEVELOPMENT; CANCER CELL; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; CYTOSKELETON; DWARFISM; ENDOCYTOSIS; ENZYME ACTIVITY; GENE MUTATION; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GLIA CELL; GLIOMA; HORMONE ACTION; HORMONE RESPONSIVE ELEMENT; HUMAN; HYPOPHYSIS TUMOR; HYPOTHYROIDISM; ION TRANSPORT; METABOLIC DISORDER; MITOCHONDRIAL GENOME; MITOCHONDRION; MOLECULAR INTERACTION; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; OXYGEN CONSUMPTION; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SODIUM CURRENT; THERMOGENESIS; THROMBOCYTE AGGREGATION; THYROID CANCER; THYROID HORMONE RESISTANCE; TRANSCRIPTION REGULATION; TUMOR CELL; ANIMAL; PHYSIOLOGY;

ANIMALS; HUMANS; RECEPTORS, THYROID HORMONE; THYROID HORMONES; THYROXINE; TRIIODOTHYRONINE;

EID: 77953639982     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2009-0007     Document Type: Review

References (298)

1. Tata JR, Widnell CC 1966 Ribonucleic acid synthesis during the early action of thyroid hormones. Biochem J 98:604-620
2. Oppenheimer JH, Schwartz HL, Surks MI 1974 Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology 95:897-903
3. Samuels HH, Tsai JS, Casanova J 1974 Thyroid hormone action: in vitro demonstration of putative receptors in isolated nuclei and soluble nuclear extracts. Science 184:1188-1191
4. Latham KR, Ring JC, Baxter JD 1976 Solubilized nuclear "receptors" for thyroid hormones. Physical characteristics and binding properties, evidence for multiple forms. J Biol Chem 251:7388-7397
5. Apriletti JW, Eberhardt NL, Latham KR, Baxter JD 1981 Affinity chromatography of thyroid hormone receptors. Biospecific elution from support matrices, characterization of the partially purified receptor. J Biol Chem 256:12094-12101
6. Apriletti JW, Baxter JD, Lavin TN 1988 Large scale purification of the nuclear thyroid hormone receptor from rat liver and sequence-specific binding of the receptor to DNA. J Biol Chem 263:9409-9417
7. Sap J, Muñoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennström B 1986 The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635-640
8. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM 1986 The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641-646
9. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1:9-18
10. Williams GR 2000 Cloning and characterization of two novel thyroid hormone receptor β isoforms. Mol Cell Biol 20:8329-8342
11. Mitsuhashi T, Tennyson GE, Nikodem VM 1988 Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone. Proc Natl Acad Sci USA 85:5804-5808
12. Plateroti M, Gauthier K, Domon-Dell C, Freund JN, Samarut J, Chassande O 2001 Functional interference between thyroid hormone receptor α (TRα) and natural truncated TR Δα isoforms in the control of intestine development. Mol Cell Biol 21:4761-4772 (Pubitemid 32588256)
13. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
14. Ribeiro RC, Kushner PJ, Baxter JD 1995 The nuclear hormone receptor gene superfamily. Annu Rev Med 46:443-453
15. Lonard DM, O'malley BW 2007 Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 27:691-700
16. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ 1995 A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
17. Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, Fletterick RJ, Baxter JD, Kushner PJ, West BL 1998 Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280:1747-1749 (Pubitemid 28283497)
18. Bradley DJ, Towle HC, Young WS 3rd 1992 Spatial and temporal expression of α- and β-thyroid hormone receptor mRNAs, including the β2-subtype, in the developing mammalian nervous system. J Neurosci 12:2288-2302
19. Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY 2003 Mutant thyroid hormone receptor β represses the expression and transcriptional activity of peroxisome proliferator-activated receptor γ during thyroid carcinogenesis. Cancer Res 63:5274-5280 (Pubitemid 37139841)
20. Jones I, Ng L, Liu H, Forrest D 2007 An intron control region differentially regulates expression of thyroid hormone-receptor β2 in the cochlea, pituitary, and cone photoreceptors. Mol Endocrinol 21:1108-1119 (Pubitemid 46984762)
21. Forrest D, Erway LC, Ng L, Altschuler R, Curran T 1996 Thyroid hormone receptor β is essential for development of auditory function. Nature Genet 13:354-357 (Pubitemid 26230504)
22. Forrest D, Hanebuth E, Smeyne RJ, Everds N, Stewart CL, Wehner JM, Curran T 1996 Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: evidence for tissue-specific modulation of receptor function. EMBO J 15:3006-3015
23. Wikström L, Johansson C, Saltó C, Barlow C, Campos Barros A, Baas F, Forrest D, Thorén P, Vennström B 1998 Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α1. EMBO J 17:455-461 (Pubitemid 28045486)
24. Fraichard A, Chassande O, Plateroti M, Roux JP, Trouillas J, Dehay C, Legrand C, Gauthier K, Kedinger M, Malaval L, Rousset B, Samarut J 1997 The T3R α gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production. EMBO J 16:4412-4420
25. Göthe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennström B, Forrest D 1999 Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13:1329-1341 (Pubitemid 29250200)
26. Yen PM, Feng X, Flamant F, Chen Y, Walker RL, Weiss RE, Chassande O, Samarut J, Refetoff S, Meltzer PS 2003 Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. EMBO Rep 4:581-587 (Pubitemid 36939949)
27. Flores-Morales A, Gullberg H, Fernandez L, Ståhlberg N, Lee NH, Vennström B, Norstedt G 2002 Patterns of liver gene expression governed by TRβ. Mol Endocrinol 16:1257-1268 (Pubitemid 34621074)
28. Zandieh Doulabi B, Platvoet-Ter Schiphorst M, Kalsbeek A, Fliers E, Bakker O, Wiersinga WM 2004 Biurnal variation in rat liver thyroid hormone receptor (TR)-α messenger ribonucleic acid (mRNA) is dependent on the biological clock in the suprachiasmatic nucleus, whereas diurnal variation of TRβ1 mRNA is modified by food intake. Endocrinology 145:1284-1289
29. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142 (Pubitemid 32606667)
30. Williams GR, Harney JW, Forman BM, Samuels HH, Brent GA 1991 Oligomeric binding of T3 receptor is required for maximal T3 response. J Biol Chem 266:19636-19644
31. Zhang XK, Kahl M 1993 Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. TEM 4:156-162 (Pubitemid 23243527)
32. Araki O, Ying H, Furuya F, Zhu X, Cheng SY 2005 Thyroid hormone receptor β mutants: dominant negative regulators of peroxisome proliferator- activated receptor γ action. Proc Natl Acad Sci USA 102:16251-16256 (Pubitemid 41688900)
33. Hansen MK, Connolly TM 2008 Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis. Curr Opin Investig Drugs 9:247-255
34. Hart CM 2008 The role of PPARγ in pulmonary vascular disease. J Investig Med 56:518-521
35. Nemenoff RA, Weiser-Evans M, Winn RA 2008 Activation and molecular targets of peroxisome proliferator-activated receptor-γ ligands in lung cancer. PPAR Res 2008:156875
36. Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE 2006 Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem 281:295-302
37. Lee JW, Ryan F, Swaffield JC, Johnston SA, Moore DD 1995 Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374:91-94
38. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
39. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
40. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
41. Leo C, Chen JD 2000 The SRC family of nuclear receptor coactivators. Gene 245:1-11
42. McInerney EM, Rose DW, Flynn SE, Westin S, Mullen TM, Krones A, Inostroza J, Torchia J, Nolte RT, Assa-Munt N, Milburn MV, Glass CK, Rosenfeld MG 1998 Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev 12:3357-3368
43. Hermanson O, Glass CK, Rosenfeld MG 2002 Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60
44. Xu J, LiQ 2003 Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17:1681-1692
45. Darimont BD, Wagner RL, Apriletti JW, Stallcup MR, Kushner PJ, Baxter JD, Fletterick RJ, Yamamoto KR 1998 Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev 12:3343-3356
46. Fondell JD, Brunel F, Hisatake K, Roeder RG 1996 Unliganded thyroid hormone receptor α can target TATA binding protein for transcriptional repression. Mol Cell Biol 16:281-287
47. Fondell JD, Ge H, Roeder RG 1996 Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci USA 93:8329-8333
48. Yuan CX, Ito M, Fondell JD, Fu ZY, Roeder RG 1998 The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA [Erratum (1998) 95:14584] 95:7939-7944
49. Rachez C, Suldan Z, Ward J, Chang CP, Burakov D, Erdjument-Bromage H, Tempst P, Freedman LP 1998 A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev 12:1787-1800
50. Glass CK, Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121-141
51. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
52. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
53. Potter GB, Beaudoin 3rd GM, DeRenzo CL, Zarach JM, Chen SH, Thompson CC 2001 The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev 15:2687-2701
54. Dressel U, Thormeyer D, Altincicek B, Paululat A, Eggert M, Schneider S, Tenbaum SP, Renkawitz R, Baniahmad A 1999 Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol 19:3383-3394
55. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
56. Wei LN, Hu X 2004 Receptor interacting protein 140 as a thyroid hormone-dependent, negative co-regulator for the induction of cellular retinoic acid binding protein I gene. Mol Cell Endocrinol 218:39-48
57. Zamir I, Dawson J, Lavinsky RM, Glass CK, Rosenfeld MG, Lazar MA 1997 Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci USA 94:14400-14405 (Pubitemid 28041385)
58. Hu X, Lazar MA 1999 The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93-96
59. Perissi V, Staszewski LM, McInerney EM, Kurokawa R, Krones A, Rose DW, Lambert MH, Milburn MV, Glass CK, Rosenfeld MG 1999 Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 13:3198-3208 (Pubitemid 30030442)
60. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J 2003 Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J 22:1336-1346
61. Guenther MG, Barak O, Lazar MA 2001 The SMRT and N-CoR corepressors are activating cofactors for histone deacetylase 3. Mol Cell Biol 21:6091-6101 (Pubitemid 34263509)
62. Lazar MA 2003 Nuclear receptor corepressors. Nucl Recept Signal 1:e001
63. Jepsen K, Hermanson O, Onami TM, Gleiberman AS, Lunyak V, McEvilly RJ, Kurokawa R, Kumar V, Liu F, Seto E, Hedrick SM, Mandel G, Glass CK, Rose DW, Rosenfeld MG 2000 Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell 102:753-763
64. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP 1998 Distinct interactions of PML-RAR α and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat Genet 18:126-135 (Pubitemid 28082458)
65. Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Rosenfeld MG, Glass C, Seto E, Hiebert SW 1998 ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol 18:7176-7184
66. Yoh SM, Chatterjee VK, Privalsky ML 1997 Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480
67. Furuya F, Guigon CJ, Zhao L, Lu C, Hanover JA, Cheng SY 2007 Nuclear receptor corepressor is a novel regulator of phosphatidylinositol 3-kinase signaling. Mol Cell Biol 27:6116-6126 (Pubitemid 47326699)
68. Sherr CJ 2002 D1 in G2. Cell Cycle 1:36-38
69. Lin HM, Zhao L, Cheng SY 2002 Cyclin D1 is a ligand-independent co-repressor for thyroid hormone receptors. J Biol Chem 277:28733-28741
70. Coqueret O 2002 Linking cyclins to transcriptional control. Gene 299:35-55
71. Zhu XG, Park KS, Kaneshige M, Bhat MK, Zhu Q, Mariash CN, McPhie P, Cheng SY 2000 The orphan nuclear receptor Ear-2 is a negative coregulator for thyroid hormone nuclear receptor function. Mol Cell Biol 20:2604-2618 (Pubitemid 30152066)
72. Riley T, Sontag E, Chen P, Levine A 2008 Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9:402-412 (Pubitemid 351574202)
73. Yap N, Yu CL, Cheng SY 1996 Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 93:4273-4277 (Pubitemid 26144276)
74. Barrera-Hernandez G, Zhan Q, Wong R, Cheng SY 1998 Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA Cell Biol 17:743-750 (Pubitemid 28462873)
75. Qi JS, Desai-Yajnik V, Yuan Y, Samuels HH 1997 Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol Cell Biol 17:7195-7207 (Pubitemid 27505950)
76. Bhat MK, Yu C, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S 1997 Tumor suppressor p53 is a negative regulator in thyroid hormone receptor signaling pathways. J Biol Chem 272:28989-28993 (Pubitemid 27498184)
77. McGough AM, Staiger CJ, Min JK, Simonetti KD 2003 The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett 552:75-81
78. Kwiatkowski DJ 1999 Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 11:103-108
79. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J 2002 Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 21:6781-6790 (Pubitemid 36014550)
80. Kim CS, Furuya F, Ying H, Kato Y, Hanover JA, Cheng SY 2007 Gelsolin: a novel thyroid hormone receptor-β interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer. Endocrinology 148:1306-1312
81. Yu R, Melmed S 2001 Oncogene activation in pituitary tumors. Brain Pathol 11:328-341
82. Pei L, Melmed S 1997 Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11:433-441 (Pubitemid 27147011)
83. Heaney AP, Nelson V, Fernando M, Horwitz G 2001 Transforming events in thyroid tumorigenesis and their association with follicular lesions. J Clin Endocrinol Metab 86:5025-5032 (Pubitemid 33020559)
84. Kim DS, McCabe CJ, Buchanan MA, Watkinson JC 2003 Oncogenes in thyroid cancer. Clin Otolaryngol Allied Sci 28:386-395
85. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S 2000 Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355:716-719
86. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S 1999 Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761-767 (Pubitemid 29075718)
87. Domínguez A, Ramos-Morales F, Romero F, Rios RM, Dreyfus F, Tortolero M, Pintor-Toro JA 1998 hPTTG, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG. Oncogene 17:2187-2193
88. Yu R, Lu W, Chen J, McCabe CJ, Melmed S 2003 Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 144:4991-4998 (Pubitemid 37378414)
89. Kim D, Pemberton H, Stratford AL, Buelaert K, Watkinson JC, Lopes V, Franklyn JA, McCabe CJ 2005 Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells. Oncogene 24:4861-4866 (Pubitemid 41076304)
90. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, Cheng S 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990
91. Ying H, Furuya F, Zhao L, Araki O, West BL, Hanover JA, Willingham MC, Cheng SY 2006 Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone β receptor inhibits mitotic progression. J Clin Invest 116:2972-2984 (Pubitemid 44684482)
92. Li X, Lonard DM, Jung SY, Malovannaya A, Feng Q, Qin J, Tsai SY, Tsai MJ, O'Malley BW 2006 The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGγ proteasome. Cell 124:381-392 (Pubitemid 43121985)
93. Gottardi CJ, Gumbiner BM 2001 Adhesion signaling: how β-catenin interacts with its partners. Curr Biol 11:R792-R794
94. Moon RT, Bowerman B, Boutros M, Perrimon N 2002 The promise and perils of Wnt signaling through β-catenin. Science 296:1644-1646 (Pubitemid 34579151)
95. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY 2008 Regulation of β-catenin by a novel nongenomic action of thyroid hormone β receptor. Mol Cell Biol 28:4598-4608
96. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, McBride OW, Weintraub BD 1988 Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA β gene. Mol Endocrinol 2:1217-1220
97. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S, DeGroot LJ 1989 Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor β. Proc Natl Acad Sci USA 86:8977-8981
98. Refetoff S, Dumitrescu AM 2007 Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21:277-305
99. Cheng SY 2005 Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol Metab 16:176-182
100. Weiss RE, Refetoff S 2000 Resistance to thyroid hormone. Rev Endocr Metab Disord 1:97-108
101. Yen PM 2003 Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333
102. Ono S, Schwartz ID, Mueller OT, Root AW, Usala SJ, Bercu BB 1991 Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab 73:990-994
103. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng S 2000 Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97:13209-13214
104. Hashimoto K, Curty FH, Borges PP, Lee CE, Abel ED, Elmquist JK, Cohen RN, Wondisford FE 2001 An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci USA 98:3998-4003
105. Kamiya Y, Zhang XY, Ying H, Kato Y, Willingham MC, Xu J, O'Malley BW, Cheng SY 2003 Modulation by steroid receptor coactivator-1 of target-tissue responsiveness in resistance to thyroid hormone. Endocrinology 144:4144-4153 (Pubitemid 37088770)
106. Siesser WB, Cheng SY, McDonald MP 2005 Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRβPV knock-in mouse. Psychopharmacology (Berl) 181:653-663
107. Griffith AJ, Szymko YM, Kaneshige M, Quiñónez RE, Kaneshige K, Heintz KA, Mastroianni MA, Kelley MW, Cheng SY 2002 Knock-in mouse model for resistance to thyroid hormone (RTH): an RTH mutation in the thyroid hormone receptor β gene disrupts cochlear morphogenesis. J Assoc Res Otolaryngol 3:279-288
108. O'Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR 2003 A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 17:1410-1424
109. Zhang XY, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P, Cheng SY 2002 Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant β receptor. Mol Endocrinol 16:2077-2092
110. Suzuki H, Cheng SY 2003 Compensatory role of thyroid hormone receptor (TR) α1 in resistance to thyroid hormone: study in mice with a targeted mutation in the TR β gene and deficient in TRα1. Mol Endocrinol 17:1647-1655
111. Kamiya Y, Puzianowska-Kuznicka M, McPhie P, Nauman J, Cheng SY, Nauman A 2002 Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33
112. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J 2002 Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87:1120-1128
113. Suzuki H, Willingham MC, Cheng SY 2002 Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969
114. Ying H, Suzuki H, Furumoto H, Walker R, Meltzer P, Willingham MC, Cheng SY 2003 Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24:1467-1479 (Pubitemid 37160837)
115. Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA 2000 PAX8-PPAR γ1 fusion oncogene in human thyroid carcinoma. Science 289:1357-1360 (Pubitemid 30656054)
116. Gustafson KS, LiVolsi VA, Furth EE, Pasha TL, Putt ME, Baloch ZW 2003 Peroxisome proliferator-activated receptor γ expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. Am J Clin Pathol 120:175-181
117. Galusca B, Dumollard JM, Chambonniere ML, Germain N, Prades JM, Péoc'h M, Estour B 2004 Peroxisome proliferator activated receptor γ immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis. Anticancer Res 24:1993-1997
118. Marques AR, Espadinha C, Frias MJ, Roque L, Catarino AL, Sobrinho LG, Leite V 2004 Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours. Br J Cancer 91:732-738
119. Kato Y, Ying H, Zhao L, Furuya F, Araki O, Willingham MC, Cheng SY 2006 PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway. Oncogene 25:2736-2747
120. Furuya F, Hanover JA, Cheng SY 2006 Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone κ receptor. Proc Natl Acad Sci USA 103:1780-1785 (Pubitemid 43228770)
121. Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY 2005 An unliganded thyroid hormone κ receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25:124-135
122. Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM 2001 Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15:1529-1538 (Pubitemid 32826405)
123. Ando S, Sarlis NJ, Oldfield EH, Yen PM 2001 Somatic mutation of TRκ can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86:5572-5576 (Pubitemid 33070290)
124. Kaneshige M, Suzuki H, Kaneshige K, Cheng J, Wimbrow H, Barlow C, Willingham MC, Cheng S 2001 A targeted dominant negative mutation of the thyroid hormone α1 receptor causes increased mortality, infertility, and dwarfism in mice. Proc Natl Acad Sci USA 98:15095-15100 (Pubitemid 34013975)
125. Tinnikov A, Nordström K, Thorén P, Kindblom JM, Malin S, Rozell B, Adams M, Rajanayagam O, Pettersson S, Ohlsson C, Chatterjee K, Vennström B 2002 Retardation of post-natal development caused by a negatively acting thyroid hormone receptor α1. EMBO J 21:5079-5087
126. Liu YY, Schultz JJ, Brent GA 2003 A thyroid hormone receptor α gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem 278:38913-38920
127. Ying H, Araki O, Furuya F, Kato Y, Cheng SY 2007 Impaired adipogenesis caused by a mutated thyroid hormone α1 receptor. Mol Cell Biol 27:2359-2371 (Pubitemid 46418487)
128. Sjö gren M, Alkemade A, Mittag J, Nordström K, Katz A, Rozell B, Westerblad H, Arner A, Vennström B 2007 Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor α1. EMBO J 26:4535-4545
129. Tagami T, Jameson JL 1998 Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone. Endocrinology 139:640-650 (Pubitemid 28513214)
130. Marimuthu A, Feng W, Tagami T, Nguyen H, Jameson JL, Fletterick RJ, Baxter JD, West BL 2002 TR surfaces and conformations required to bind nuclear receptor corepressor. Mol Endocrinol 16:271-286 (Pubitemid 34131225)
131. Angel RC, Botta JA, Farias RN 1989 High affinity L-triiodothyronine binding to right-side-out and inside-out vesicles from rat and human erythrocyte membranes. J Biol Chem 264:19143-19146
132. 2+-ATPase activity in vitro. Correlations between hormone structure and biological activity in a human cell system. J Biol Chem 258:12373-12377
133. 125I] triiodothyronine to human peripheral leukocytes and its internalization. Experientia 43:1117-1118
134. Blondeau JP 1986 Saturable binding of thyroid hormone to isolated rat hepatocytes. FEBS Lett 204:41-46 (Pubitemid 16017735)
135. 2+)-adenosine triphosphatase from rat erythrocyte. J Biol Chem 256:7113-7114
136. Segal J, Ingbar SH 1979 Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest 63:507-515 (Pubitemid 9130215)
137. Craelius W, Green WL, Harris DR 1990 Acute effects of thyroid hormone on sodium currents in neonatal myocytes. Biosci Rep 10:309-315 (Pubitemid 20283359)
138. Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY 2006 Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res 66:7270-7275
139. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ 2005 Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146:2864-2871
140. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW 2000 Ligand binding to integrins. J Biol Chem 275:21785-21788
141. Tsou R, Isik FF 2001 Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 224:81-89 (Pubitemid 32962654)
142. Shih A, Zhang S, Cao HJ, Tang HY, Davis FB, Davis PJ, Lin HY 2004 Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-α are mediated by 3′,5′-cyclic adenosine 5′-monophosphate-α dependent protein kinase II. Endocrinology 145:1708-1717
143. Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ 2008 Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor. Angiogenesis 11:183-190
144. Lin HY, Tang HY, Shih A, Keating T, Cao G, Davis PJ, Davis FB 2007 Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72:180-187
145. Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ 2004 Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145:3265-3272
146. Rebbaa A, Chu F, Davis FB, Davis PJ, Mousa SA 2008 Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent. Angiogenesis 11:269-276
147. Yalcin M, Lansing L, Bharali D, Bridoux A, Davis FB, Lin HY, Rebbaa A, Davis PJ, Mousa SA, Tetrac and nanoparticulate tetrac arrest growth and inhibit tumor angiogenesis in xenografts of human medullary carcinoma of the thyroid. Program of the 79th Annual Meeting of The American Thyroid Association, Chicago, IL, 2008 (Abstract 110). Thyroid 18(Suppl 1):S46
148. Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ 2009 L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol 296:C980-C991
149. Moeller LC, Cao X, Dumitrescu AM, Seo H, Refetoff S 2006 Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor β through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 4:e020
150. Lei J, Mariash CN, Ingbar DH 2004 3,3′,5-Triiodo-L-thyronine up-regulation of Na, K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase-and phosphoinositide 3-kinase-dependent. J Biol Chem 279:47589-47600
151. Storey NM, Gentile S, Ullah H, Russo A, Muessel M, Erxleben C, Armstrong DL 2006 Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 103:5197-5201
152. Giguère A, Lehoux JG, Gallo-Payet N, Bellabarba D 1992 3,5,3′-Triiodothyronine binding sites in synaptosomes from brain of chick embryo. Properties and ontogeny. Brain Res Dev Brain Res 66:221-227
153. Giguère A, Fortier S, Beaudry C, Gallo-Payet N, Bellabarba D 1996 Effect of thyroid hormone on G proteins in synaptosomes of chick embryo. Endocrinology 137:2558-2564
154. Baumann CT, Maruvada P, Hager GL, Yen PM 2001 Nuclear cytoplasmic shuttling by thyroid hormone receptors. Multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-11245
155. Zhu XG, Hanover JA, Hager GL, Cheng SY 1998 Hormone-induced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem 273:27058-27063
156. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB 2000 Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039
157. S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol Endocrinol 19:102-112
158. Moeller LC, Dumitrescu AM, Refetoff S 2005 Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1α glycolytic genes. Mol Endocrinol 19:2955-2963
159. Lei J, Nowbar S, Mariash CN, Ingbar DH 2003 Thyroid hormone stimulates Na, K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 285:L762-L772
160. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK 2006 Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103:14104-14109
161. Davis PJ, Leonard JL, Davis FB 2008 Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 29:211-218
162. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH2008 T3 increases Na, K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 294:L749-L754
163. 3 translocation. J Biol Chem 264:4864-4871
164. 3 translocation. Biochem Biophys Res Commun 174:1084-1089
165. Davis PJ, Handwerger BS, Glaser F 1974 Physical properties of a dog liver and kidney cytosol proteins that binds thyroid hormone. J Biol Chem 249:6208-6217
166. Vié MP, Blanchet P, Samson M, Francon J, Blondeau JP 1996 High affinity thyroid hormone-binding in human kidney: kinetic characterization and identification by photoaffinity labeling. Endocrinology 137:4563-4570
167. Parkison C, Ashizawa K, McPhie P, Lin KH, Cheng SY 1991 The monomer of pyruvate kinase, subtype M1, is both a kinase and a cytosolic thyroid hormone binding protein. Biochem Biophys Res Commun 179:668-674
168. Kobayashi M, Hashizume K, Suzuki S, Ichikawa K, Takeda T 1991 A novel, NADPH-dependent cytosolic 3,5,3′-triiodo-L-thyronine-binding protein (CTBP; 5.1 S) in rat liver: a comparison with a 4.7 S NADPH-dependent CTBP. Endocrinology 129:1701-1708
169. Kato H, Fukuda T, Parkison C, McPhie P, Cheng SY 1989 Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase. Proc Natl Acad Sci USA 86:7861-7865
170. 2+-ATPase activity. J Clin Invest 71:579-586
171. Segal J, Hardiman J, Ingbar SH 1989 Stimulation of calcium-ATPase activity by 3,5,3′-tri-iodothyronine in rat thymocyte plasma membranes. A possible role in the modulation of cellular calcium concentration. Biochem J 261:749-754
172. Lawrence WD, Schoenl M, Davis PJ 1989 Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J Biol Chem 264:4766-4768
173. Nieman LK, Davis FB, Davis PJ, Cunningham EE, Gutman S, Blas SD, Schoenl M 1983 Effect of end-stage renal disease on responsiveness to calmodulin and thyroid hormone of calcium-ATPase in human red blood cells. Kidney Int Suppl 16:S167-S170
174. 2+-ATPase activity. J Clin Endocrinol Metab 62:253-257
175. Marino F, Guasti L, Cosentino M, De Piazza D, Simoni C, Piantanida E, Cimpanelli M, Klersy C, Bartalena L, Venco A, Lecchini S 2006 Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. Life Sci 78:1071-1077
176. Zinman T, Shneyvays V, Tribulova N, Manoach M, Shainberg A 2006 Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J Cell Physiol 207:220-231
177. Kahaly GJ, Dillmann WH 2005 Thyroid hormone action in the heart. Endocr Rev 26:704-728
178. 2+-ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100:380-389
179. Dillmann WH 2002 Cellular action of thyroid hormone on the heart. Thyroid 12:447-452
180. 2+-ATPase activity and share structural homologies. Proc Natl Acad Sci USA 82:7974-7978
181. + regulation in normal and failing hearts. J Pharmacol Sci 100:315-322
182. 2+ activity in adult rat cerebrocortical synaptosomes by 3-5-3′-L- triiodothyronine. Neurosci Res Commun 31:193-201
183. 2+ level and activation of nitric oxide synthase in adult rat cerebral cortex pretreated with 3,5,3′-L-triiodothyronine. Neuropsychopharmacology 22:36-41
184. Sarkar PK, Durga ND, Morris JJ, Martin JV 2006 In vitro thyroid hormone rapidly modulates protein phosphorylation in cerebrocortical synaptosomes from adult rat brain. Neuroscience 137:125-132
185. Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS, McBride WJ, Novotny MV, Pedrick NM, Ringham HN, Simon JR 2005 A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 5:2177-2201
186. Hagemann D, Xiao RP 2002 Dual site phospholamban phosphorylation and its physiological relevance in the heart. Trends Cardiovasc Med 12:51-56
187. 2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res 57:20-27
188. Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E 2005 Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions. Cardiovasc Res 68:366-375
189. 2+-ATPase. Biochemistry 47:3-13
190. Segal J, Ingbar SH 1981 Studies of the mechanism by which 3,5,3′-triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3′:5′-monophsophate. J Clin Invest 68:103-110
191. Segal J, Ingbar SH 1989 Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,5,3′-triiodothyronine in rat thymocytes. Endocrinology 124:1949-1955
192. Segal J, Ingbar SH 1989 3,5,3′-Triiodothyronine increases cellular adenosine 3′:5′-monophosphate concentration and sugar uptake in rat thymocytes by stimulating adenylate cyclase activity: studies with the adenylate cyclase inhibitor MDL 12330A. Endocrinology 124:2166-2171
193. Segal J 1989 A rapid, extranuclear effect of 3,5,3′- triiodothyronine on sugar uptake by several tissues in the rat in vivo. Evidence for a physiological role for the thyroid hormone action at the level of the plasma membrane. Endocrinology 124:2755-2764
194. Bhargava M, Lei J, Mariash CN, Ingbar DH 2007 Thyroid hormone rapidly stimulates alveolar Na, K-ATPase by activation of phosphatidylinositol 3-kinase. Curr Opin Endocrinol Diabetes Obes 14:416-420
195. +-ATPase activity in adult rat cerebrocortical synaptosomes. Neuroreport 9:1149-1152
196. Gick GG, Ismail-Beigi F, Edelman IS 1988 Thyroidal regulation of rat renal and hepatic Na, K-ATPase gene expression. J Biol Chem 263:16610-16618
197. Incerpi S, Luly P, De Vito P, Farias RN 1999 Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3′,5-triiodo-Lthyronine. Endocrinology 140:683-689
198. D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ 2004 Rapid nongenomic effects of 3,5,3′-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145:5694-5703
199. Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH 2006 Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 mice. Biochem Pharmacol 71:1162-1174
200. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK 2009 Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 297:E1238-E1246
201. Davis PJ, Davis FB, Cody V 2005 Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 16:429-435
202. Roepe PD 1992 Analysis of the steady-state and initial rate of doxorubicin efflux from a series of multidrug-resistant cells expressing different levels of P-glycoprotein. Biochemistry 31:12555-125664
203. Harris DR, Green WL, Craelius W 1991 Acute thyroid hormone promotes slow inactivation of sodium in neonatal cardiac myocytes. Biochim Biophys Acta 1095:175-181
204. Huang CJ, Geller HM, Green WL, Craelius W 1999 Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J Mol Cell Cardiol 31:881-893
205. Yonkers MA, Ribera AB 2008 Sensory neuron sodium current requires nongenomic actions of thyroid hormone during development. J Neurophysiol 100:2719-2725
206. Yonkers MA, Ribera AB 2009 Molecular components underlying nongenomic thyroid hormone signaling in embryonic zebrafish neurons. Neural Dev 4:e20
207. Stachelek SJ, Kowalik TF, Farwell AP, Leonard JL 2000 Myosin V plays an essential role in the thyroid hormone-dependent endocytosis of type II iodothyronine 5′ deiodinase. J Biol Chem 275:31701-31707
208. Baqui M, Botero D, Gereben B, Curcio C, Harney JW, Salvatore D, Sorimachi K, Larsen PR, Bianco AC 2003 Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J Biol Chem 278:1206-1211
209. Smythe E, Ayscough KR 2006 Actin regulation in endocytosis. J Cell Sci 119:4589-4598
210. Mendelsohn J, Baselga J 2006 Epidermal growth factor receptor targeting in cancer. Semin Oncol 33:369-385 (Pubitemid 44142736)
211. Pietras RJ 2003 Interactions between estrogen and growth factor receptors in human breast cancer and the tumor-associated vasculature. Breast J 9:361-373
212. Ciardiello F, Tortora G 2008 EGFR antagonists in cancer treatment. N Engl J Med 358:1160-1174
213. Ren H, Yang BF, Rainov NG 2007 Receptor tyrosine kinases as therapeutic targets in malignant glioma. Rev Recent Clin Trials 2:87-101
214. Cao HJ, Lin HY, Luidens MK, Davis FB, Davis PJ 2009 Cytoplasm-to-nucleus shuttling of thyroid hormone receptor β1 (TRβ1) is directed from a plasma membrane integrin receptor by thyroid hormone. Endocr Res 34:31-42
215. Lin HY, Zhang S, West BL, Tang HY, Passaretti T, Davis FB, Davis PJ 2003 Identification of the putative MAP kinase docking site in the thyroid hormone receptor-β1 DNA-binding domain: function consequences of mutations at the docking site. Biochemistry 42:7571-7579
216. Chen Y, Chen PL, Chen CF, Sharp ZD, Lee WH 1999 Thyroid hormone, T3-dependent phosphorylation and translocation of Trip230 from the Golgi complex to the nucleus. Proc Natl Acad Sci USA 96:4443-4448
217. Lin HY, Martino LJ, Wilcox BD, Davis FB, Gordinier JK, Davis PJ 1998 Potentiation by thyroid hormone of human IFN- γ-induced HLA-DR expression. J Immunol 161:843-849 (Pubitemid 28323549)
218. Silva CM 2004 Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene 23:8017-8023
219. Shih A, Lin HY, Davis FB, Davis PJ 2001 Thyroid hormone promotes phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40:2870-2878 (Pubitemid 32198289)
220. Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, Cohen BH, Stevens GH, Reddy SK, Peereboom DM, Elson PJ, Gupta MK, Barnett GH 2003 Propylthiouracil- induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a Phase I/II study. Anticancer Res 23:617-626
221. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Leonard JL 2006 Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology 147:2567-2574
222. Farwell AP, Lynch RM, Okulicz WC, Comi AM, Leonard JL 1990 The actin cytoskeleton mediates the hormonally regulated translocation of type II iodothyronine 5′ deiodinase in astrocytes. J Biol Chem 265:18546-18553
223. 3), GC-1 or diiodothyropropionic acid (DITPA). Clin Appl Thromb Hemost doi: 1076029609348315v1
224. El Eter E, Rabee H, Alkayali A, Mousa SA 2007 Role of thyroid hormone analogs in angiogenesis and the development of collaterals in rabbit hind limb ischemia model. J Thromb Haemost 5 (Suppl 1):375
225. Tomanek RJ, Zimmerman MB, Suvarna PR, Morkin E, Pennock GD, Goldman S 1998 A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart. J Mol Cell Cardiol 30:923-932 (Pubitemid 28279305)
226. Schlenker EH, Hora M, Liu Y, Redetzke RA, Morkin E, Gerdes AM 2008 Effects of thyroidectomy, T4, and DITPA on replacement of brain blood vessel density in adult rats. Am J Physiol Regul Integr Comp Physiol 294:R1504-R1509
227. Kuzman JA, Tang Y, Vogelsang KA, Said S, Anderson BE, Morkin E, Gerdes AM 2007 Thyroid hormone analog, diiodothyropropionic acid (DITPA), exerts beneficial effects on chamber and cellular remodeling in cardiomyopathic hamsters. Can J Physiol Pharmacol 85:311-318 (Pubitemid 47262235)
228. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ 2004 Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94:1500-1506 (Pubitemid 38780323)
229. Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ 2005 The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 46:356-360
230. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN 2005 Thyroid hormone and breast cancer. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122-1128
231. Gorman CA, Becker DV, Greenspan FS, Levy RP, Oppenheimer JH, Rivlin RS, Robbins J, Vanderlaan WP 1977 Breast cancer and thyroid therapy. Statement by the American Thyroid Association. JAMA 237:1459-1460
232. Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D, Sun M, Hercbergs A, Davis FB, Davis PJ 2008 Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 29:62-69 (Pubitemid 351201742)
233. Puymirat J, Etongue-Mayer P, Dussault JH 1995 Thyroid hormones stabilize acetylcholinesterae mRNA in neuron-2A cells that overexpress the β1 thyroid receptor. J Biol Chem 270:30651-30656 (Pubitemid 26005129)
234. Vandenbrouck Y, Janvier B, Loriette C, Bereziat G, Mangeney-Andreani M 1995 Thyroid hormone modulates apolipoprotein-AI gene expression at the post-transcriptional level in Hep G2 cells. Eur J Biochem 231:126-132
235. Guerra C, Roncero C, Porras A, Fernández M, Benito M 1996 Triiodothyronine induces the transcription of the uncoupling protein gene and stabilizes its mRNA in fetal rat brown adipocyte primary cultures. J Biol Chem 271:2076-2081 (Pubitemid 26047794)
236. Ashizawa K, McPhie P, Lin KH, Cheng SY 1991 Anin vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1,6-bisphosphate. Biochemistry 30:7105-7111
237. Ashizawa K, Cheng SY 1992 Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein. Proc Natl Acad Sci USA 89:9277-9281
238. Harper ME, Seifert EL 2008 Thyroid hormone effects on mitochondrial energetics. Thyroid 18:145-156 (Pubitemid 351271528)
239. Kim B 2008 Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18:141-144 (Pubitemid 351271535)
240. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, Hill DE, Vidal M, Evans JG, Thorburn DR, Carr SA, Mootha VK 2008 A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112-123
241. Wagner BK, Kitami T, Gilbert TJ, Peck D, Ramanathan A, Schreiber SL, Golub TR, Mootha VK 2008 Large-scale chemical dissection of mitochondrial function. Nat Biotechnol 26:343-351 (Pubitemid 351355127)
242. Brand MD, Pakay JL, Ocloo A, Kokoszka J, Wallace DC, Brookes PS, Cornwall EJ 2005 The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem J 392:353-362 (Pubitemid 41796524)
243. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr, Lowell BB 2006 Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets. Cell Metab 3:417-427 (Pubitemid 43811776)
244. Ledesma A, de Lacoba MG, Rial E 2002 The mitochondrial uncoupling proteins. Genome Biol 3, Reviews 3015
245. Brand MD 2005 The efficiency and plasticity of mitochondrial energy transduction. Biochem Soc Trans 33:897-904
246. Cadenas S, Echtay KS, Harper JA, Jekabsons MB, Buckingham JA, Grau E, Abuin A, Chapman H, Clapham JC, Brand MD 2002 The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J Biol Chem 277:2773-2778 (Pubitemid 34953307)
247. Couplan E, del Mar Gonzalez-Barroso M, Alves-Guerra MC, Ricquier D, Goubern M, Bouillaud F 2002 No evidence for a basal, retinoic, or superoxide-induced uncoupling activity of the uncoupling protein 2 present in spleen or lung mitochondria. J Biol Chem 277:26268-26275 (Pubitemid 34967116)
248. Pecqueur C, Couplan E, Bouillaud F, Ricquier D 2001 Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J Mol Med 79:48-56 (Pubitemid 32250022)
249. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM 1999 Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124
250. Fisher RP, Lisowsky T, Parisi MA, Clayton DA 1992 DNA wrapping and bending by a mitochondrial high mobility group-like transcriptional activator protein. J Biol Chem 267:3358-3367
251. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ 2000 Heart mitochondrial DNA and enzyme changes during early human development. Mol Cell Biochem 210:47-52 (Pubitemid 30629068)
252. Garstka HL, Fäcke M, Escribano JR, Wiesner RJ 1994 Stoichiometry of mitochondrial transcripts and regulation of gene expression by mitochondrial transcription factor A. Biochem Biophys Res Commun 200:619-626 (Pubitemid 24183652)
253. Wrutniak C, Cassar-Malek I, Marchal S, Rascle A, Heusser S, Keller JM, Fléchon J, Dauça M, Samarut J, Ghysdael J 1995 A 43-kDa protein related to c-Erb A α 1 is located in the mitochondrial matrix of rat liver. J Biol Chem 270:16347-16354
254. Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G, Wrutniak C 1999 A variant form of the nuclear triiodothyronine receptor c-ErbAα1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19:7913-7924
255. Andersson ML, Vennström B 1997 Chicken thyroid hormone receptor α requires the N-terminal amino acids for exclusive nuclear localization. FEBS Lett 416:291-296
256. Saelim N, Holstein D, Chocron ES, Camacho P, Lechleiter JD 2007 Inhibition of apoptotic potency by ligand stimulated thyroid hormone receptors located in mitochondria. Apoptosis 12:1781-1794
257. Saelim N, John LM, Wu J, Park JS, Bai Y, Camacho P, Lechleiter JD 2004 Nontranscriptional modulation of intracellular Ca2+ signaling by ligand stimulated thyroid hormone receptor. J Cell Biol 167:915-924
258. Siegrist-Kaiser CA, Juge-Aubry C, Tranter MP, Ekenbarger DM, Leonard JL 1990 Thyroxine-dependent modulation of actin polymerization in cultured astrocytes. Anovel, extranuclear action of thyroid hormone. J Biol Chem 265:5296-5302
259. Leonard JL, Farwell AP 1997 Thyroid hormone-regulated actin polymerization in brain. Thyroid 7:147-151
260. Venstrom KA, Reichardt LF 1993 Extracellular matrix 2: Role of extracellular matrix molecules and their receptors in the nervous system. FASEB J 7:996-1003
261. Liesi P 1990 Extracellular matrix and neuronal movement. [Review]. Experientia 46:900-907
262. Liesi P, Silver J 1988 Is astrocyte laminin involved in axon guidance in the mammalian CNS? Develop Biol 130:774-785
263. Liesi P 1985 Laminin-immunoreactive glia distinguish regenerative adult CNS systems from non-regenerative ones. EMBO J 4:2505-2511
264. Liesi P 1985 Do neurons in the vertebrate CNS migrate on laminin? EMBO J 4:1163-1170
265. Liesi P, Hager G, Dodt HU, Seppä lä I, Zieglgänsberger W 1995 Domain-specific antibodies against the B2 chain of laminin inhibit neuronal migration in the neonatal rat cerebellum. J Neurosci Res 40:199-206
266. Hager G, Dodt HU, Zieglgänsberger W, Liesi P 1995 Novel forms of neuronal migration in the rat cerebellum. J Neurosci Res 40:207-219
267. Ruoslahti E 1991 Integrins. J Clin Invest 87:1-5
268. Hynes RO 1992 Integrin: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
269. Farwell AP, Tranter MP, Leonard JL 1995 Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes. Endocrinology 136:3909-3915
270. Farwell AP, Dubord SA 1996 Thyroid hormone regulates neurite outgrowth and neuronal migration onto laminin. Thyroid 6(Suppl 1):S-6
271. Farwell AP, Dubord-Tomasetti SA 1999 Thyroid hormone regulates the extracellular organization of laminin on astrocytes. Endocrinology 140:5014-5021
272. Farwell AP, Dubord-Tomasetti SA 1999 Thyroid hormone regulates the expression of laminin in the developing rat cerebellum. Endocrinology 140:4221-4227
273. Dodd J, Jessell TM 1988 Axon guidance and the patterning of neuronal projections in vertebrates. Science 242:692-699
274. Tessier-Lavigne M, Goodman CS 1996 The molecular biology of axon guidance. Science 274:1123-1133
275. Smith SJ 1988 Neuronal cytomechanics: the actin-based motility of growth cones. Science 242:708-715
276. Hatten ME, Mason CA 1990 Mechanisms of glial-guided neuronal migration in vitro and in vivo. Experientia 46:907-916
277. Hatten ME 1993 The role of migration in central nervous system neuronal development. Curr Opin Neurobiol 3:38-44
278. Rivas RJ, Hatten ME 1995 Motility and cytoskeletal organization of migrating cerebellar granule neurons. J Neurosci 15:981-989
279. Marsh L, Letourneau PC 1984 Growth of neurites without filapodial or lamellipodial activity in the presence of cytochalasin B. J Cell Biol 99:2041-2047
280. Bentley D, Toroian-Raymond A 1986 Disoriented path-finding by pioneer neuron growth cones deprived of filopodia by cytochalasin treatment. Nature 323:712-715
281. Forscher P, Smith SJ 1988 Actions of cytochalasins on the organization of the actin filaments and microtubules in a neuronal growth cone. J Cell Biol 107:1505-1516
282. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ, Leonard JL 2005 Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3′,5′-triiodothyronine. Brain Res Dev Brain Res 154:121-135
283. Safran M, Farwell AP, Rokos H, Leonard JL 1993 Structural requirements of iodothyronines for the rapid inactivation and internalization of type II iodothyronine 5′-deiodinase in glial cells. J Biol Chem 268:14224-14229
284. Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, Laudet V, Samarut J 1997 Identification of transcripts initiated from an internal promoter in the c-erbA α locus that encode inhibitors of retinoic acid receptor-α and triiodothyronine receptor activities. Mol Endocrinol 11:1278-1290
285. Flamant F, Samarut J 2003 Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 14:85-90
286. Morte B, Manzano J, Scanlan T, Vennström B, Bernal J 2002 Deletion of the thyroid hormone receptor α 1 prevents the structural alterations of the cerebellum induced by hypothyroidism. Proc Natl Acad Sci USA 99:3985-3989
287. Lazar MA 1990 Sodium butyrate selectively alters thyroid hormone receptor gene expression in GH3 cells. J Biol Chem 265:17474-17477
288. 3H] uridine transport by thyroid hormone in GH1 cells. Evidence for regulation by the thyroid hormone nuclear receptor. J Biol Chem 261:9400-9404
289. Duncan KG, Jumper MD, Ribeiro RC, Bailey KR, Yen PM, Sugawara A, Patel A, Stern R, Chin WW, Baxter JD, Schwartz DM 1999 Human trabecular meshwork cells as a thyroid hormone target tissue: presence of functional thyroid hormone receptors. Graefes Arch Clin Exp Ophthalmol 237:231-240
290. Mariash CN, McSwigan CR, Towle HC, Schwartz HL, Oppenheimer JH 1981 Glucose and triiodothyronine both induce malic enzyme in the rat hepatocyte culture: evidence that triiodothyronine multiplies a primary glucose-generated signal. J Clin Invest 68:1485-1490
291. Murata Y, Ceccarelli P, Refetoff S, Horwitz AL, Matsui N 1987 Thyroid hormone inhibits fibronectin synthesis by cultured human skin fibroblasts. J Clin Endocrinol Metab 64:334-339
292. Christoffolete MA, Ribeiro R, Singru P, Fekete C, da Silva WS, Gordon DF, Huang SA, Crescenzi A, Harney JW, Ridgway EC, Larsen PR, Lechan RM, Bianco AC 2006 Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147:1735-1743
293. Cao Z, West C, Norton-Wenzel CS, Rej R, Davis FB, Davis PJ, Rej R 2009 Effects of resin or charcoal treatment on fetal bovine and bovine calf serum. Endocr Res 34:101-108
294. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898-938
295. St Germain DL, Galton VA, Hernandez A 2009 Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology 150:1097-1107
296. Gereben B, Zeöld A, Dentice M, Salvatore D, Bianco AC 2008 Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences. Cell Mol Life Sci 65:570-590
297. Heuer H, Visser TJ 2009 Minireview: pathophysiological importance of thyroid hormone transporters. Endocrinology 150:1078-1083
298. van der Deure W, Peeters R, Visser T 18 June 2009 Molecular aspects of thyroid hormone transporters, including MCT8, MCT10 and OATPs, and the effects of genetic variation in these transporters. J Mol Endocrinol doi:10.1677/JME-09-0042